118 related articles for article (PubMed ID: 8283807)
1. [A clinical study of pepsinogen I and II producing gastric carcinomas].
Kodoi A; Haruma K; Yoshihara M; Shimamoto T; Watanabe C; Okamoto S; Kawaguchi H; Tari A; Sumii K; Kajiyama G
Nihon Shokakibyo Gakkai Zasshi; 1993 Dec; 90(12):2971-8. PubMed ID: 8283807
[TBL] [Abstract][Full Text] [Related]
2. Pepsinogens in gastric carcinomas.
Busby-Earle RM; Williams AR; Piris J
Hum Pathol; 1986 Oct; 17(10):1031-5. PubMed ID: 3759061
[TBL] [Abstract][Full Text] [Related]
3. Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.
Huang SC; Miki K; Sano J; Ichinose M; Kawamura N; Oka H; Hirano K; Furihata C; Masugi Y; Takahashi K
Jpn J Cancer Res; 1988 Oct; 79(10):1139-46. PubMed ID: 3143702
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical study and cellular localization of human pepsinogens during ontogenesis and in gastric cancers.
Hirsch-Marie H; Loisillier F; Touboul JP; Burtin P
Lab Invest; 1976 Jun; 34(6):623-32. PubMed ID: 778486
[TBL] [Abstract][Full Text] [Related]
5. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
Stemmermann GN; Samloff IM; Hayashi T
Appl Pathol; 1985; 3(3):159-63. PubMed ID: 3915949
[TBL] [Abstract][Full Text] [Related]
6. [An immunohistochemical study of pepsinogen type C in the gastric mucosa and in stomach cancer].
Frank GA; Pugachev KK; Belous TA; Shimbireva IB; Fofanov VI; Petrov AN; Shabalov KP
Arkh Patol; 1995; 57(1):39-43. PubMed ID: 7771929
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
8. Group I pepsinogen for early detection of gastric cancer recurrence after total gastrectomy.
Kodama M; Koyama K; Tsuburaya Y; Ishikawa K; Koyama H; Narisawa T; Uesaka Y
World J Surg; 1990; 14(1):94-9; discussion 99-100. PubMed ID: 2305591
[TBL] [Abstract][Full Text] [Related]
9. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
10. The relation of serum pepsinogen to gastric cancer and its precursors in Hawaii Japanese men: a progress report.
Stemmermann GN; Heilbrun LK; Nomura A; Samloff IM
Prog Clin Biol Res; 1985; 173():213-20. PubMed ID: 3983194
[TBL] [Abstract][Full Text] [Related]
11. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
12. Gastric phenotypic expression in human gallbladder cancers revealed by pepsinogen immunohistochemistry and mucin histochemistry.
Tatematsu M; Ichinose M; Miki K; Tatematsu K; Kishikawa H; Ito N
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):25-32. PubMed ID: 3131954
[TBL] [Abstract][Full Text] [Related]
13. Serum pepsinogens as a screening test of extensive chronic gastritis.
Miki K; Ichinose M; Shimizu A; Huang SC; Oka H; Furihata C; Matsushima T; Takahashi K
Gastroenterol Jpn; 1987 Apr; 22(2):133-41. PubMed ID: 3596151
[TBL] [Abstract][Full Text] [Related]
14. Slow moving proteinase in gastric cancer and its relationship to pepsinogens I and II. An immunohistochemical study.
Shiraishi T; Samloff IM; Taggart RT; Stemmermann GN
Dig Dis Sci; 1988 Nov; 33(11):1466-72. PubMed ID: 3053074
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogens I and II and stomach cancer.
Stemmermann GN; Samloff IM; Nomura AM; Heilbrun LK
Clin Chim Acta; 1987 Mar; 163(2):191-8. PubMed ID: 3568423
[TBL] [Abstract][Full Text] [Related]
16. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
19. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry.
Tatematsu M; Ichinose M; Miki K; Hasegawa R; Kato T; Ito N
Acta Pathol Jpn; 1990 Jul; 40(7):494-504. PubMed ID: 2220396
[TBL] [Abstract][Full Text] [Related]
20. [A case of a gastric cancer patient with high serum pepsinogen levels at relapse].
Kimura Y; Fujii T; Miyagawa N; Tanada S; Hamamoto K; Kimura S
Gan No Rinsho; 1990 Jul; 36(8):945-8. PubMed ID: 2366328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
